Gene · 7134
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria? | Open Heart | 2026 | 41565355 | PubTator, text mining | PubMed |
| Effect of levosimendan treatment in cardiac surgery: a network meta-analysis of randomized controlled trials. | Front Cardiovasc Med | 2025 | 41756164 | PubTator, text mining | PubMed |
| Effect of levosimendan on plasma intestinal barrier factors in heart failure patients with reduced ejection fraction. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 41492745 | PubTator, text mining | PubMed |
| A Comprehensive Mass Spectrometry-Based Proteomic Dataset of Human Spermatozoa. | Sci Data | 2025 | 40877368 | PubTator, text mining | PubMed |
| The Yin and Yang of Heartbeats: Magnesium-Calcium Antagonism Is Essential for Cardiac Excitation-Contraction Coupling. | Cells | 2025 | 40862759 | PubTator, text mining | PubMed |
| Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. | Diabetes Metab Res Rev | 2025 | 40831067 | PubTator, text mining | PubMed |
| Analytical and clinical evaluation of an automated high-sensitivity cardiac troponin I assay for whole blood. | Clin Chem Lab Med | 2025 | 40811682 | PubTator, text mining | PubMed |
| Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational study. | Front Pediatr | 2025 | 40809383 | PubTator, text mining | PubMed |
| Cardiac Troponin C E135A Variant Impairs Myofilament Response to PKA Phosphorylation and Is Associated With Autosomal Dominant Dilated Cardiomyopathy With Diastolic Dysfunction. | Circ Genom Precis Med | 2025 | 40671656 | PubTator, text mining | PubMed |
| Prognostic significance of calcium-related genes in lung adenocarcinoma and the role of TNNC1 in macrophage polarization and erlotinib resistance. | Front Immunol | 2025 | 40433361 | PubTator, text mining | PubMed |
| ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment'. | Eur Heart J Suppl | 2025 | 40385469 | PubTator, text mining | PubMed |
| 5,7-Dimethoxychroman-3-yl 4-methoxybenzoate Has a Unique Effect upon the Modulation of Mutant Cardiac Muscle Thin Filament Function and Dynamics due to Phosphorylation of Troponin I. | ACS Pharmacol Transl Sci | 2025 | 40370989 | PubTator, text mining | PubMed |
| Investigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies. | Sci Rep | 2025 | 40369053 | PubTator, text mining | PubMed |
| Fuling Wenxin formula treats "Qi-Yin deficiency" arrhythmia by regulating the dilated cardiomyopathy and adrenergic signaling pathway in cardiomyocytes. | Phytomedicine | 2025 | 40319835 | PubTator, text mining | PubMed |
| Integrated meta-analysis and network pharmacology analysis: evaluation of Zhigancao decoction as treatment for diabetic cardiomyopathy. | Front Cardiovasc Med | 2025 | 40161384 | PubTator, text mining | PubMed |
| A satellite cell-dependent epigenetic fingerprint in skeletal muscle identity genes after lifelong physical activity. | FASEB J | 2025 | 40047419 | PubTator, text mining | PubMed |
| Molecular Markers of Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients. | Front Biosci (Landmark Ed) | 2025 | 40018925 | PubTator, text mining | PubMed |
| Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel. | J Am Coll Cardiol | 2025 | 39971408 | PubTator, text mining | PubMed |
| An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models. | J Clin Invest | 2025 | 39959972 | PubTator, text mining | PubMed |
| Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction. | J Adv Res | 2025 | 39870300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7134/papers?page=2